A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Ophthalmic Market Data, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsLatest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 350
Comprehensive Pages
- 40
Competitor Profiles
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2022 IOL Market Report: Global Analysis for 2021 to 2027, April, 2022
The “2022 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.
Latest Industry News & Trends
9/23/2022
BreakingEuropePharmaRegulationRetina
Roche’s Vabysmo Gains EU Approval for Wet AMD, DME
Swiss drugmaker Roche announced Sept. 19 that the European Commission had approved Vabysmo (faricimab) for the treatment of wet age-related macular degeneration (AMD) and visual impairment due to d...
9/23/2022
BiosimilarsBreakingRetina
Coherus Plans to Launch Lucentis Biosimilar Cimerli in US in October 2022
Coherus BioSciences announced Sept. 19 that its ranibizumab biosimilar, Cimerli, will be commercially available in the US beginning Oct. 3, 2022. Cimerli (ranibizumab-eqrn) was approved by the US F...
9/23/2022
BreakingDry EyePharmaRegulation
Akorn to Pay $7.9 Million to Resolve Case Involving False Medicare Claims
Pharmaceutical company Akorn has agreed to pay $7.9 million to resolve allegations that it caused the submission of false claims to Medicare Part D for three generic drugs, including an ophthalmic ...
9/23/2022
BreakingSurgical
Court Rules in Favor of UnitedHealth Over Facility Fees for Office-Based Surgery
A federal court ruled Sept. 14 that UnitedHealth is not required to pay facility fees for office-based surgery. Plaintiffs were a group of doctors from New York. They claimed that UnitedHealth rece...
9/23/2022
BreakingDealsDiagnosticDry Eye
Verséa Ophthalmics Gains Global License to Axim’s Dry Eye Diagnostics
Axim Biotechnologies announced Sept. 19 that it had signed an exclusive global commercial partnership deal with Verséa Ophthalmics, a division of Verséa Holdings. Verséa gains exclusive commercial ...
9/23/2022
BreakingChinaClinical TrialRetina
Chinese Regulators Approve Phase III Trial of Belite Bio’s Oral Stargardt Candidate
Belite Bio announced Sept. 16 that the National Medical Products Administration (NMPA) of China had approved a Phase III trial of LBS-008 (tinlarebant), Belite’s oral treatment candidate for Starga...
9/23/2022
BreakingIndustryRetina
Johnson & Johnson Opens New R&D Hub in Bay Area; Retinal Program Part of Broad Focus
Johnson & Johnson, of New Brunswick, New Jersey, reported Sept. 20 that it had opened a new 200 thousand-square-foot R&D facility in the San Francisco area that will integrate drug discovery, data ...
9/23/2022
BreakingIndustryMicroscopes
Haag-Streit Transfers Microscope Production to New Site in Switzerland
Swiss company Haag-Streit announced Aug. 25 the opening of a new state-of-the-art surgical microscope production site in Aesch, Switzerland. The company said it has moved production of its surgical...
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Over 500 Clients, Large & Small, Have Trusted Market Scope Data & Analysis
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.